Skip to main content

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 25))

Abstract

The rationale for the design of structural analogues of a normal metabolite is that such compounds may interfere in the utilization or function of the metabolite. A compound which is effective in this respect may be called an antimetabolite. To be successful in chemotherapy of bacterial, viral, or tumor growth, an antimetabolite should adversely affect some vital metabolic reactions in the parasite or parasitic tissue without seriously endangering the host tissue. If a metabolic process of the offending growth is different from that of the host, it is likely that the metabolism or activity of a compound, structurally related to a metabolite involved in that process, will also be different in these cells. Such differences are useful for devising effective drugs with selective actions. Sulfanilamide, a structural analogue of para-aminobenzoic acid, interferes with the utilization of this metabolite in the synthesis of folic acid, an essential factor for growth. Bacteria synthesize their own folic acid and are incapable of utilizing exogenously available folic acid. However, the situation is exactly opposite in the animal host. That is, animal tissues cannot synthesize folic acid and are absolutely dependent upon exogenous sources. These differences in metabolism make possible the use of sulfanilamide as a selective inhibitor of growth. Other antibacterial or antiparasitic drugs, such as penicillin (Burchall, Ferone and Hitchings, 1965) and inhibitors of dihydrofolate reductase (Hitchings and Burchall, 1965; Hitchings, 1964; Burchall and Hitchings, 1965) have analogous desirable selective toxicity effects. Unfortunately, there are few qualitative differences in the metabolism of normal and neoplastic tissues. This fact has made the selective toxicity approach less applicable to cancer chemotherapy. However, it has become increasingly clear that there are quantitative differences which can be utilized as a rational approach to cancer chemotherapy. These considerations are based on the rate of metabolism and the state of cellular structures and are directly related to the rapid growth and multiplication of neoplastic cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1970 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Roy-Burman, P. (1970). Introduction. In: Roy-Burman, P. (eds) Analogues of Nucleic Acid Components. Recent Results in Cancer Research, vol 25. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85576-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85576-4_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85578-8

  • Online ISBN: 978-3-642-85576-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics